nach oben

Erschienen in:

01.05.2022 | Unknown

FDA limits authorised use of Janssen COVID-19 vaccine

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

The USA FDA has limited the authorised use of the Janssen COVID-19 vaccine [Ad26.COV2-S] to adults for whom other COVID-19 vaccines are not accessible or appropriate, or who elect to receive the Janssen vaccine because they would not receive another COVID-19 vaccine. …

Coronavirus (COVID-19) Update: FDA Limits Use of Janssen COVID-19 Vaccine to Certain Individuals Internet Document : 11 May 2022. Available from: URL: https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-limits-use-janssen-covid-19-vaccine-certain-individuals

Titel: FDA limits authorised use of Janssen COVID-19 vaccine
Publikationsdatum: 01.05.2022
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-14892-2

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

FDA limits authorised use of Janssen COVID-19 vaccine

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2022

Antineoplastics

Multiple drugs

Lidocaine

Mogamulizumab

Multiple drugs

Dexamethasone/fluorometholone/loteprednol-etabonate